An Intravenous Polymer Hemostat for Noncompressible Hemorrhage and Traumatic Brain Injury
Abstract
This project directly addresses the focus area, Innovative and novel technologies that can stop life-threatening bleeding in the torso region of patients who are delayed in receiving definitive surgical care. The goal of this project is to test the effect of a novel intravenous hemostatic biopolymer on noncompressible truncal hemorrhage and traumatic brain injury (TBI) in experimental models. This project seeks to test its effects on critical aspects of the pathophysiology of polytrauma, including TBI, blood loss, and resuscitation during simulated tactical combat casualty care. Results will be used to guide further development of the biopolymer for translation to human use within the next 5-10 years and will ultimately benefit Service Members and the public by providing a new and improved therapy for TBI and severe trauma casualties.
Document Details
- Document Type
- DoD Grant Award
- Publication Date
- Dec 28, 2022
- Source ID
- W81XWH2210063
Entities
People
- Nathan J White
Organizations
- United States Army
- University of Washington